Tu canal independiente de oncología en español
Top resúmenes y presentaciones
ESMO 2024
GINECOLÓGICO
Regístrate aquí para recibir más contenidos
Registrarse
CERVICAL
Induction chemotherapy followed by chemoradiation in
locally advanced cervical cancer: quality of life outcomes of
the GCIG INTERLACE trial.
710MO
Efficacy and Safety of Sacituzumab Tirumotecan
(sac-TMT) Plus Pembrolizumab in Patients with Recurrent
or Metastatic Cervical Cancer
716MO
Primary results from BEATcc (ENGOT-Cx10/GEICO
68-C/JGOG1084/GOG-3030), a randomised phase III trial of
first-line atezolizumab (atezo) combined with a platinum
doublet and bevacizumab (bev) for metastatic (stage IVB),
persistent or recurrent cervical cancer (R/M CC)
VP5-
2023
Pembrolizumab plus chemoradiotherapy for high-risk
locally advanced cervical cancer: Overall survival results
from the randomized, double-blind, phase 3
ENGOT-cx11/GOG-3047/KEYNOTE-A18 study
709O